These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4001800)

  • 41. [Characteristics of the central-peripheral relation in depressive states].
    Sinitskiĭ VN
    Fiziol Zh (1978); 1984; 30(4):393-401. PubMed ID: 6147277
    [No Abstract]   [Full Text] [Related]  

  • 42. Effects of prenatal restraint stress on the hypothalamus-pituitary-adrenal axis and related behavioural and neurobiological alterations.
    Maccari S; Morley-Fletcher S
    Psychoneuroendocrinology; 2007 Aug; 32 Suppl 1():S10-5. PubMed ID: 17651905
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of postnatal isolation rearing and antidepressant treatment on the density of serotonergic and noradrenergic axons and depressive behavior in rats.
    Kuramochi M; Nakamura S
    Neuroscience; 2009 Sep; 163(1):448-55. PubMed ID: 19524023
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Panic disorder and major depression: biological relationships.
    Roy-Byrne PP; Uhde TW
    Psychopharmacol Bull; 1985; 21(3):551-4. PubMed ID: 4034872
    [No Abstract]   [Full Text] [Related]  

  • 45. [Activity of the enzymes participating in the metabolism of biogenic amines in patients with depressive syndromes. I. Platelet monoamine oxidase (MAO) activity].
    Matsumoto H; Pietruszewska I; Roguska E
    Psychiatr Pol; 1983; 17(1):7-11. PubMed ID: 6622594
    [No Abstract]   [Full Text] [Related]  

  • 46. [Concentration of biogenic amines in the central and peripheral nervous systems of rats with portacaval shunts, and their changes following administration of pargyline and levodopa].
    Alsasua A; Arias J; López-Sánchez ML; Estébanez E; Arias JI; García de Jalón PD; Durán Sacristán H
    Arch Farmacol Toxicol; 1982 Aug; 8(2):83-92. PubMed ID: 7159104
    [No Abstract]   [Full Text] [Related]  

  • 47. Depression: biological and neuroendocrine aspects.
    Tolis G; Stefanis C
    Biomed Pharmacother; 1983; 37(7):316-22. PubMed ID: 6141819
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Biological vulnerability to depressive disorders].
    Poirier-Littré MF
    Encephale; 1994 Dec; 20 Spec No 4():629-38. PubMed ID: 7895629
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Blood level of gamma-aminobutyric acid--"peripheral index" of the state of central neuromediator system].
    Mishunina TM
    Vopr Med Khim; 1998; 44(6):511-9. PubMed ID: 10599136
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Action of lithium on the central nervous system].
    Majczak A; Grzywa A
    Pol Tyg Lek; 1973 Oct; 28(43):1704-5. PubMed ID: 4587427
    [No Abstract]   [Full Text] [Related]  

  • 51. [Experimental and clinical characteristics of the Soviet antidepressant inkasan].
    Mashkovskiĭ MD; Andreeva NI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(3):410-3. PubMed ID: 6720183
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Biogenic amine study of Glycera convoluta K. (Annelida, Polychaeta)].
    Manaranche R; L'Hermite P
    Z Zellforsch Mikrosk Anat; 1973 Feb; 137(1):21-36. PubMed ID: 4734957
    [No Abstract]   [Full Text] [Related]  

  • 53. Depressive symptoms moderate the influence of hostility on serum interleukin-6 and C-reactive protein.
    Stewart JC; Janicki-Deverts D; Muldoon MF; Kamarck TW
    Psychosom Med; 2008 Feb; 70(2):197-204. PubMed ID: 18256345
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Release of neurohormones and neurotransmitters in the median eminence of the rat.
    Stoeckart R
    Acta Morphol Neerl Scand; 1972 Dec; 10(4):386. PubMed ID: 4657712
    [No Abstract]   [Full Text] [Related]  

  • 55. Distinctive somatosensory evoked potential features in obsessive-compulsive disorder.
    Shagass C; Roemer RA; Straumanis JJ; Josiassen RC
    Biol Psychiatry; 1984 Nov; 19(11):1507-24. PubMed ID: 6518205
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Depressive states and biological markers].
    Boyer P
    Rev Prat; 1985 May; 35(27):1627-32. PubMed ID: 4001800
    [No Abstract]   [Full Text] [Related]  

  • 57. [Features of cerebral-somatic and metabolic shifts in older patients with depressive states].
    Sinitskiĭ VN; Usherenko LS; Kryzhanovskaia LA; Zapotochnyĭ BA; Ugarova OP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(4):551-9. PubMed ID: 6730821
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human growth hormone in psychiatric disorders.
    de la Fuente JR; Wells LA
    J Clin Psychiatry; 1981 Jul; 42(7):270-4. PubMed ID: 7016846
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Biological markers of depression].
    Landowski J
    Psychiatr Pol; 1987; 21(3):180-9. PubMed ID: 2892219
    [No Abstract]   [Full Text] [Related]  

  • 60. Is depression a neurologic disease?
    Brumback RA
    Neurol Clin; 1993 Feb; 11(1):79-104. PubMed ID: 8441375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.